De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control " always " matter?

被引:0
作者
Lorini, L. [1 ,8 ]
Gili, R. [2 ]
Salvestrini, V. [3 ]
Morelli, I. [4 ]
Smussi, D. [5 ]
Petrelli, F. [6 ]
Bonomo, P.
Bossi, P. [1 ,7 ]
机构
[1] IRCCS Humanitas Res Hosp, Med Oncol & Hematol Unit, Via Manzoni 56, I-20089 Milan, Italy
[2] IRCCS Osped Policlin San Martino, Med Oncol Unit, I-16132 Genoa, Italy
[3] Univ Florence, Radiat Oncol Unit, Azienda Osped Univ Careggi, Florence, Italy
[4] Univ Florence, Dept Expt & Clin Biomed Sci, Radiat Oncol Unit, Azienda Osped Univ Careggi, Florence, Italy
[5] Univ Brescia, Dept Med & Surg Specialties, Med Oncol Unit, Radiol Sci & Publ Hlth,ASST Spedali Civil, I-25123 Brescia, Italy
[6] ASST Bergamo Ovest, Oncol Unit, Treviglio, Italy
[7] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20072 Milan, Italy
[8] Via Manzoni 56,0282241, I-20089 Rozzano, Italy
关键词
De novo metastatic head and neck squamous; cell carcinoma; Radiation; Immunotherapy; Quality of Life; CLINICAL-PRACTICE GUIDELINES; NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY; OPEN-LABEL; CHEMOTHERAPY; DIAGNOSIS; SURVIVAL; CARE;
D O I
10.1016/j.oraloncology.2024.106768
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
De novo metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) constitutes 10% of recurrent/metastatic (RM) cases. Radiotherapy (RT) has a crucial role in the treatment of locally advanced HNSCC, however its application on RM diseases is still limited. The advent of immune checkpoint inhibitors (ICIs) improves the survival of RM HNSCC, however median overall survival is still limited. Integration of locoregional RT with ICIs in de novo metastatic HNSCC represents a promising treatment option. This perspective aims to explore the role of the combination of locoregional and systemic treatment in improving outcomes for synchronous de novo metastatic HNSCC patients and highlights the principal crucial point in decision making.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Radiation therapy on primary tumour of synchronous metastatic head and neck squamous cell carcinomas
    Tang, E.
    Nguyen, T-V-F
    Clatot, F.
    Rambeau, A.
    Johnson, A.
    Sun, X. S.
    Tao, Y.
    Thariat, J.
    [J]. CANCER RADIOTHERAPIE, 2020, 24 (6-7): : 559 - 566
  • [42] Management of metastatic head and neck squamous cell carcinomas
    Saada, E.
    Ferrand, F. -R.
    Peyrade, F.
    Guigay, J.
    [J]. ONCOLOGIE, 2015, 17 (5-6) : 245 - 249
  • [43] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [44] Systemic treatment of metastatic squamous cell carcinoma of the head and neck: proposal for management changes
    Peyrade, Frederic
    Borel, Christian
    Daste, Amaury
    Even, Carolie
    Saada-Bouzid, Esma
    Guigay, Joel
    [J]. CURRENT OPINION IN ONCOLOGY, 2021, 33 (03) : 160 - 167
  • [45] Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma
    Kabarriti, Rafi
    Baliga, Sujith
    Ohri, Nitin
    Guha, Chandan
    Kalnicki, Shalom
    Garg, Madhur K.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (01): : 130 - 138
  • [46] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1856 - 1867
  • [47] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    [J]. ORAL ONCOLOGY, 2023, 140
  • [48] Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
    Hanna, Glenn J.
    Liu, Hongye
    Jones, Robert E.
    Bacay, Alyssa F.
    Lizotte, Patrick H.
    Ivanova, Elena V.
    Bittinger, Mark A.
    Cavanaugh, Megan E.
    Rode, Amanda J.
    Schoenfeld, Jonathan D.
    Chau, Nicole G.
    Haddad, Robert I.
    Lorch, Jochen H.
    Wong, Kwok-Kin
    Uppaluri, Ravindra
    Hammerman, Peter S.
    [J]. ORAL ONCOLOGY, 2017, 67 : 61 - 69
  • [49] Current status of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Jacob, L. A.
    Chaudhuri, T.
    Lakshmaiah, K. C.
    Babu, K. G.
    Dasappa, L.
    Babu, M. C. S.
    Rudresha, A. H.
    Lokesh, K. N.
    Rajeev, L. K.
    [J]. INDIAN JOURNAL OF CANCER, 2016, 53 (04) : 1 - 7
  • [50] Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study
    Vasiliadou, Ifigenia
    Breik, Omar
    Baker, Holly
    Leslie, Isla
    Sim, Van Ren
    Hegarty, Gemma
    Michaelidou, Andriana
    Nathan, Kannon
    Hartley, Andrew
    Good, James
    Sanghera, Paul
    Fong, Charles
    Urbano, Teresa Guerrero
    Lei, Mary
    Petkar, Imran
    Ferreira, Miguel Reis
    Nutting, Chris
    Wong, Kee Howe
    Newbold, Kate
    Harrington, Kevin
    Bhide, Shree
    Kong, Anthony
    [J]. CANCERS, 2021, 13 (06) : 1 - 12